Skip to content
Tenfell
Awarded contract
Published 27 May 2015

Pharmacovigilance Management Services

Cell Therapy Catapult Limited · United Kingdom

Key facts

Contract value
£47,000
Awarded
03 Aug 2015
Contract starts
15 Aug 2015
Contract ends
31 Mar 2018
Procedure
Other -
Buyer type
Local government

Awarded to

SupplierValue
Diamond PV£47,000

Description

The Cell Therapy Catapult is managing the conduct of a phase I/II clinical trial to test primarily the acute safety and tolerability, and longer term efficacy, of a cell therapy product in patients with Acute Respiratory Distress Syndrome.

Pharmacovigilance/Safety Management services are required to cover standard clinical trial tasks including: SAE handling/reporting; production of safety management plan, narratives, safety alert letters; single case reporting, periodic/annual reporting, DSMB reporting and conducting safety reviews).

A DSMB will convene on approximately 4 occasions to review interim, unblinded safety data. The primary analysis for safety and efficacy will be performed once the last subject in Cohort 3 completes the Day 28 visit. This is a product that has previously been given to over 200 patients (including UK) in other disease areas.

Additional information: Bidders wishing to submit a tender are requested to complete the attached response document, including the requested attachments and return them to [email protected] by the closing date which is 13.00 30th June 2015

Bidders wishing to seek clarifications in relation to the tender or associated documentation may submit queries to [email protected]. The closing date for tender clarifications is 13.00 on 19th June 2015.

Categories (CPV)

Similar open tenders

About Cell Therapy Catapult Limited

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.